Pablo Perez-Pinera
For More Information
Resident Instruction
- ENDOCRINOLOGY - CARLE ILLINOIS COLLEGE OF MEDICINE
- BIOE202 - CELL AND TISSUE ENGINEERING LAB
- BIOE460 - GENE EDITING LAB
- BIOE306 - BIOFABRICATION LAB
Research Interests
- Neuromuscular diseases
- Neurodegenerative diseases
- Biopharmaceutical Production
- Gene Therapy
- Regenerative Medicine
- Genome Engineering
- Synthetic Biology
Selected Articles in Journals
- Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ, Gersbach CA. Nat Methods. 2013 Mar;10(3):239-42.
- RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Perez-Pinera P, Kocak DD, Vockley CM, Adler AF, Kabadi AM, Polstein LR, Thakore PI, Glass KA, Ousterout DG, Leong KW, Guilak F, Crawford GE, Reddy TE, Gersbach CA. Nat Methods. 2013 Oct;10(10):973-6.
- CRISPR-SKIP: programmable gene splicing with single base editors. Gapinske M, Luu A, Winter J, Woods WS, Kostan KA, Shiva N, Song JS, Perez-Pinera P. Genome Biol. 2018 Aug 15;19(1):107.
- Brown A, Winter J, Gapinske M, Tague N, Woods WS, Perez-Pinera P. Multiplexed and tunable transcriptional activation by promoter insertion using nuclease-assisted vector integration. Nucleic Acids Res. 2019 Jul 9;47(12):e67
- Winter J, Luu A, Gapinske M, Manandhar S, Shirguppe S, Woods WS, Song JS, Perez-Pinera P. Targeted Exon Skipping with AAV-Mediated Split Adenine Base Editors. Cell Discovery. 2019 Aug 20;5:41
- Lim CKW, Gapinske M, Brooks AK, Woods WS, Powell JE, Zeballos C MA, Winter J, Perez-Pinera P*, Gaj T*. Treatment of a Mouse Model of ALS by In Vivo Base Editing. Mol Ther. 2020 Apr 8;28(4):1177-1189. *Co-corresponding authors.
- Lim CKW, McCallister TX, Saporito-Magriña C, McPheron GD, Krishnan R, Zeballos C MA, Powell JE, Clark LV, Perez-Pinera P*, Gaj T*. CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes. Mol Ther. 2022 Dec 7;30(12):3619-3631. *Co-corresponding authors.
- Gapinske M, Winter J, Swami D, Gapinske L, Woods WS, Shirguppe S, Miskalis A, Busza A, Joulani D, Kao CJ, Kostan K, Bigot A, Bashir R, Perez-Pinera P. Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors. Mol Ther Nucleic Acids. 2023 Jul 27;33:572-586.
Service to Federal and State Government
- TAG study section member
Recent Courses Taught
- BIOE 202 - Cell & Tissue Engineering Lab
- BIOE 297 PPP - Individual Study
- BIOE 306 - Biofabrication Lab
- BIOE 460 - Gene Editing Lab
- BIOE 497 PP2 (BIOE 497 PPP) - Individual Study
- BIOE 498 PP1 (BIOE 498 PP2) - Experimental Genetic Eng.